Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
Major trial tests skipping radiation for Low-Risk breast cancer
Disease control Not yet recruitingThis study looks at whether women with a very early form of breast cancer called DCIS, who have a low-risk genetic score, can safely avoid radiation therapy after lumpectomy. About 5,270 women will be enrolled and followed to see if skipping radiation leads to a similar rate of c…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New hope for head and neck cancer patients who Can't take standard chemo
Disease control Not yet recruitingThis study tests two different treatments for people with advanced head and neck cancer who cannot receive the standard drug cisplatin. Participants will get radiation therapy along with either the targeted drug cetuximab or a combination of two chemotherapy drugs, carboplatin an…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New radiation rhythm may boost brain cancer survival and save memory
Disease control Not yet recruitingThis study tests a new way of giving radiation therapy, called TMPRT, for people with a fast-growing brain cancer (glioblastoma) that is unlikely to respond to standard chemo. About 398 adults will get either standard radiation or TMPRT, both with the chemo drug temozolomide. The…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 04, 2026 16:24 UTC